RESUMEN
Amyloid fibrils were isolated from spleen and thyroid obtained at autopsy from one patient (S.K.O.) of Jewish origin with familial amyloidotic polyneuropathy. Gel filtration on Sephadex G100 after solubilization in 5 M guanidine HCl yielded three major components with 14,000, 9,000, and 5,000 mol wt, respectively. The two larger components shared antigenic determinants with human prealbumin. Amino acid analysis and amino terminal sequence studies revealed the 14,000-mol wt protein to be an intact prealbumin subunit. The 9,000-mol wt fragment obtained in highest yield encompassed the region from position 49-127 and the 5,000 mol wt fraction encompassed the amino terminal of prealbumin (position 1-48). An amino acid substitution (Gly/Thr) was detected at position 49, where enzymatic cleavage occurred. Thus, several prealbumin-derived fragments, predominantly the carboxyl end, constitute the amyloid fibrils in a heredofamilial amyloidosis syndrome of dominant inheritance.
Asunto(s)
Amiloide/análisis , Amiloidosis/genética , Enfermedades del Sistema Nervioso/genética , Prealbúmina/análisis , Albúmina Sérica/análisis , Adulto , Secuencia de Aminoácidos , Amiloide/inmunología , Epítopos , Humanos , Judíos , Masculino , Enfermedades del Sistema Nervioso/metabolismo , Prealbúmina/genética , Prealbúmina/inmunologíaRESUMEN
Familial amyloidosis, Finnish type (FAF), is an autosomal dominant form of familial amyloid polyneuropathy. The novel amyloid fibril protein found in these patients is a degradation fragment of gelsolin, an actin-binding protein. We found a mutation (adenine for guanine) at nucleotide 654 of the gelsolin gene in genomic DNA isolated from five FAF patients. This site is polymorphic since the normal allele was also present in all the patients tested. This mutation was not found in two unaffected family members and 11 normal controls. The A for G transition causes an amino acid substitution (asparagine for aspartic acid) that was found at position 15 of the amyloid protein. The mutation and consequent amino acid substitution may lead to the development of FAF.
Asunto(s)
Amiloidosis/genética , Proteínas de Unión al Calcio/genética , Genes , Proteínas de Microfilamentos/genética , Mutación , Secuencia de Aminoácidos , Secuencia de Bases , ADN/genética , ADN/aislamiento & purificación , Finlandia , Gelsolina , Humanos , Linfocitos/metabolismo , Datos de Secuencia Molecular , Sondas de Oligonucleótidos , Reacción en Cadena de la PolimerasaRESUMEN
Isolated amyloid fibrils from three cases of systemic senile amyloidosis (SSA) contained subunit proteins with molecular masses of 14 (10-20%), 10-12 (60-80%), and 5-6 kD (5-10%) when fractionated under reducing and dissociating conditions. This grouping was identical to that seen in SKO, a case of familial amyloidotic polyneuropathy (FAP) studied earlier. Amino acid sequencing confirmed that SSA subunit proteins were in fact prealbumin (transthyretin). Complete sequence analysis of one SSA preparation revealed the presence of a new variant Pa (TTr) molecule with a single amino acid substitution of isoleucine for valine at position 122. Further studies used an antiserum specific for SKO IV, a subunit protein of SKO previously shown to correspond to carboxy-terminal 78 residues (positions 49-127) of (TTr). Anti-SKO IV reacted with SSA in tissue at equivalent dilutions to anti-Pa (TTr) and with the 10-12-kD fraction of SSA on Western blots; reactivity was blocked by SKO IV, but not by Pa (TTr). SSA is a form of systemic amyloidosis caused by tissue deposition of Pa (TTr) and its fragments, with shared conformational or subunit antigenicity to at least one form of FAP. Identification of a new variant Pa (TTr) molecule in one case suggests further that SSA may be a genetically determined disease expressed late in life.
Asunto(s)
Amiloidosis/metabolismo , Miocardio/análisis , Enfermedades del Sistema Nervioso/metabolismo , Prealbúmina/análisis , Secuencia de Aminoácidos , Amiloide/análisis , Amiloidosis/genética , Western Blotting , Electroforesis en Gel de Poliacrilamida , Variación Genética , Humanos , Técnicas para Inmunoenzimas , Datos de Secuencia Molecular , Peso Molecular , Enfermedades del Sistema Nervioso/etiología , Fragmentos de Péptidos , Prealbúmina/genéticaRESUMEN
Curvilinear fibrils with the tinctorial properties of amyloid were isolated from a patient with bone and joint involvement complicating chronic dialysis for renal disease. Subunit fractions of 24,000 and 12,000 mol wt were identified after gel filtration under dissociating conditions, the latter containing a significant amount of a dimer of the former. This was confirmed by Edman degradation of each fraction, which yielded the amino terminal sequence of normal human beta-2 microglobulin (B2M) to residues 20 and 30, respectively. The size of the subunit protein (12,000 mol wt) and the amino acid composition make it likely that intact B2M is a major constituent of the fibrils. B2M is thus another example of a low molecular weight serum protein, with a prominent beta-pleated sheet structure, that may adopt the fibrillar configuration of amyloid in certain pathologic states.
Asunto(s)
Amiloide/metabolismo , Amiloidosis/metabolismo , Microglobulina beta-2/metabolismo , Anciano , Secuencia de Aminoácidos , Amiloidosis/complicaciones , Enfermedades Óseas/complicaciones , Enfermedades Óseas/metabolismo , Humanos , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/metabolismo , MasculinoRESUMEN
Gerstmann-Sträussler-Scheinker (GSS) disease is a cerebral prion protein (PrP) amyloidosis associated with mutations in the PrP gene (PRNP). A GSS disease variant with mutation at codon 198 (F198S) has been studied in a large Indiana kindred. Biochemical investigations showed that the amyloid protein consists of 11 and 7 kDa fragments of PrP. Immunohistochemical studies showed that in addition to amyloid, these patients accumulate PrP deposits which are neither fluorescent nor birefringent when stained with thioflavin S and Congo red. In the present paper, we analyzed proteinase-K (PK)-resistant PrP in 7 patients with GSS F198S disease. Immunoblots of PK-treated brain extracts show prominent bands of ca. 27-29, 18-19, and 8 kDa. Immunohistochemistry and thioflavin-S-fluorescence show that the amyloid deposits are conspicuous in the cerebellum but sparse in the caudate nucleus. However, immunoblot analysis reveals PK-resistant PrP bands of similar intensity in both regions. Treatment with PK and PNGase F generates a pattern similar to that of PK alone. Our findings suggest that brain extracts from GSS F198S disease contain 3 prominent nonglycosylated PK-resistant PrP fragments forming a pattern not previously described in other prion diseases, which may in part explain the pathology of this GSS disease variant.
Asunto(s)
Endopeptidasa K/farmacología , Enfermedad de Gerstmann-Straussler-Scheinker/metabolismo , Priones/efectos de los fármacos , Priones/metabolismo , Adulto , Anciano , Amiloide/metabolismo , Encéfalo/metabolismo , Encéfalo/patología , Síndrome de Creutzfeldt-Jakob/metabolismo , Síndrome de Creutzfeldt-Jakob/patología , Resistencia a Medicamentos , Enfermedad de Gerstmann-Straussler-Scheinker/genética , Enfermedad de Gerstmann-Straussler-Scheinker/patología , Humanos , Immunoblotting , Isomerismo , Persona de Mediana Edad , Fracciones Subcelulares/metabolismoRESUMEN
The prion protein (PrP) plays an essential role in the pathogenesis of a group of sporadic, genetically determined and infectious fatal degenerative diseases, referred to as "prion diseases", affecting the central nervous system of humans and other mammals. The cellular PrP is encoded by a single copy gene, highly conserved across mammalian species. In prion diseases, PrP undergoes conformational changes involving a shift from alpha-helix to beta-sheet structure. This conversion is important for PrP amyloidogenesis, which occurs to the highest degree in the genetically determined Gerstmann-Sträussler-Scheinker disease (GSS) and prion protein cerebral amyloid angiopathy (PrP-CAA), while it is less frequently seen in other prion diseases. GSS and PrP-CAA are associated with point mutations of the prion protein gene (PRNP); these conditions show a broad spectrum of clinical presentation, the main signs being ataxia, spastic paraparesis, extrapyramidal signs and dementia. In GSS, parenchymal amyloid may be associated with spongiform changes or neurofibrillary lesions; in PrP-CAA, vascular amyloid is associated with neurofibrillary lesions. A major component of the amyloid fibrils in the two diseases is a 7 kDa peptide, spanning residues 81-150 of PrP.
Asunto(s)
Amiloidosis/patología , Encefalopatías/genética , Encéfalo/patología , Enfermedad de Gerstmann-Straussler-Scheinker/genética , Enfermedades por Prión/patología , Priones/química , Priones/genética , Secuencia de Aminoácidos , Amiloidosis/genética , Animales , Secuencia de Bases , Encefalopatías/patología , Codón , Secuencia Conservada , Femenino , Genotipo , Enfermedad de Gerstmann-Straussler-Scheinker/patología , Humanos , Masculino , Mamíferos , Linaje , Mutación Puntual , Enfermedades por Prión/genética , Estructura Secundaria de Proteína , Scrapie/genética , Scrapie/patologíaRESUMEN
Apolipoprotein E (apoE) has been found in association with several different types of systemic and cerebral amyloid deposits and the presence of the epsilon 4 allele constitutes a risk factor for Alzheimer's disease. It has been shown that apoE binds and promotes the fibrillogenesis in vitro of Alzheimer's amyloid beta-peptide, suggesting an important role for apoE in the modulation of amyloidogenesis. Due to the co-localization of apoE with several biochemically distinct amyloid deposits, it has been proposed that apoE plays a general role modulating and/or participating in amyloidosis. In the present study, we show for the first time that apoE, isolated from human plasma, increases fibril formation of synthetic peptides comprising the amyloidogenic sequences of gelsolin amyloid related to familial amyloidosis Finnish type, and amyloid A found in secondary amyloidosis and familial Mediterranean fever. Our results suggest that apoE acts as a general pathological chaperone in various amyloidoses by enhancing the transition from soluble peptides into amyloid-forming, pathological molecules.
Asunto(s)
Enfermedad de Alzheimer/metabolismo , Apolipoproteínas E/farmacología , Gelsolina/farmacología , Neurofibrillas/efectos de los fármacos , Proteína Amiloide A Sérica/farmacología , Secuencia de Aminoácidos , Gelsolina/química , Humanos , Sustancias Macromoleculares , Microscopía Electrónica , Datos de Secuencia Molecular , Neurofibrillas/ultraestructura , Fragmentos de Péptidos/química , Fragmentos de Péptidos/farmacología , Proteína Amiloide A Sérica/química , Espectrometría de FluorescenciaRESUMEN
Gerstmann-Sträussler-Scheinker disease in the Indiana kindred is pathologically characterized by prion protein amyloid deposits and neurofibrillary tangles (NFT) with paired helical filaments (PHF). Using antibodies to various domains of the tau molecule, we investigated the composition of PHF in this family by immunocytochemistry and immunoblot analysis. The results indicate that A68 is a component of NFT in this family as it is in Alzheimer's disease, and suggest that post-translational modifications of tau leading to formation of A68 are not unique to Alzheimer's disease.
Asunto(s)
Corteza Cerebral/patología , Enfermedad de Gerstmann-Straussler-Scheinker/patología , Proteínas del Tejido Nervioso/análisis , Ovillos Neurofibrilares/patología , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/patología , Corteza Cerebral/ultraestructura , Enfermedad de Gerstmann-Straussler-Scheinker/genética , Humanos , Immunoblotting , Inmunohistoquímica , Indiana , Persona de Mediana Edad , Ovillos Neurofibrilares/ultraestructura , Proteínas tauRESUMEN
Cerebral amyloid angiopathy (CAA) refers to a group of hereditary (hereditary cerebral hemorrhage with amyloidosis, HCHWA and sporadic (SCAA) disorders characterized by amyloid fibril deposition restricted to the leptomeningeal and cortical vasculature leading to recurrent hemorrhagic and/or ischemic accidents. On clinical and biochemical grounds, two forms of HCHWA can be distinguished. The amyloid subunit of the HCHWA of Icelandic origin is related to Cystatin C, while amyloid from patients of Dutch origin (HCHWA-D) is related to the beta-protein (or A4), the main component of vascular and plaque core amyloid in Alzheimer's disease (AD) and Down's syndrome (DS) [corrected]. SCAA is an increasingly recognized cause of stroke in normotensive individual amounting to 5-10% of all cerebrovascular accidents. We now report the isolation and partial amino acid sequence of the amyloid subunit from a case of SCAA and a new case of HCHWA-D. The recognition that a heterogeneous group of diseases are linked by similar pathological and chemical features suggests that diversity of etiological factors may promote a common pathogenetic mechanism leading to amyloid-beta (A beta) deposition, and open new ways of research in AD and CAA as they are related to dementia and stroke.
Asunto(s)
Enfermedad de Alzheimer/metabolismo , Amiloide/aislamiento & purificación , Amiloidosis/metabolismo , Hemorragia Cerebral/metabolismo , Trastornos Cerebrovasculares/metabolismo , Enfermedad de Alzheimer/patología , Secuencia de Aminoácidos , Amiloide/metabolismo , Péptidos beta-Amiloides , Amiloidosis/patología , Hemorragia Cerebral/patología , Trastornos Cerebrovasculares/patología , HumanosRESUMEN
An 82 year-old man was referred for joint pain and numbness of his hands. Physical examination revealed limitation of movement of the PIP's, MCP's, wrists, shoulders and knees. There was marked synovial thickening of the wrists and atrophy of the thenar muscles of both hands due to arpal tunnel syndrome. The patient was operated on both hands, the median nerves were released and a synovectomy of the wrist was performed. Two months later, a synovectomy of the right shoulder was performed. Histological examination of tissues from the wrists and shoulder demonstrated large deposits of amyloid in the synovia. Amyloid fibrils were extracted, solubilized in 6M and were fractionated on a Sepharose 6B. All three proteins that were purified from the amyloid fibrils proved to be derived from VkI light chain by their amino terminal sequences. This is the first amyloid protein to be characterized from amyloid arthropathy.
Asunto(s)
Amiloide/análisis , Amiloidosis/patología , Proteína Amiloide A Sérica/análisis , Membrana Sinovial/análisis , Anciano , Amiloidosis/diagnóstico , Electroforesis en Gel de Poliacrilamida , Humanos , MasculinoAsunto(s)
Inmunoglobulina G/aislamiento & purificación , Animales , Centrifugación por Gradiente de Densidad/métodos , Cromatografía por Intercambio Iónico/métodos , Disulfuros/análisis , Electroforesis en Gel de Almidón/métodos , Humanos , Inmunoglobulina G/clasificación , Cadenas Pesadas de Inmunoglobulina/aislamiento & purificación , Cadenas Ligeras de Inmunoglobulina/aislamiento & purificación , Indicadores y Reactivos , Sustancias Macromoleculares , Papaína , Pepsina A , Fragmentos de Péptidos/análisis , Proteína Estafilocócica A , TripsinaAsunto(s)
Inmunoglobulina A , Alquilación , Secuencia de Aminoácidos , Aminoácidos/análisis , Radioisótopos de Carbono , Fenómenos Químicos , Química , Cromatografía en Gel , Disulfuros , Electroforesis , Humanos , Inmunoglobulina A/análisis , Fragmentos de Inmunoglobulinas/análisis , Cadenas Pesadas de Inmunoglobulina/análisis , Yodoacetatos , Oxidación-ReducciónRESUMEN
Significant outbreaks of prion disease linked to oral exposure of the prion agent have occurred in animal and human populations. These disorders are associated with a conformational change of a normal protein, PrP(C) (C for cellular), to a toxic and infectious form, PrP(Sc) (Sc for scrapie). None of the prionoses currently have an effective treatment. Some forms of prion disease are thought to be spread by oral ingestion of PrP(Sc), such as chronic wasting disease and variant Creutzfeldt-Jakob disease. Attempts to obtain an active immunization in wild-type animals have been hampered by auto-tolerance to PrP and potential toxicity. Previously, we demonstrated that it is possible to overcome tolerance and obtain a specific anti-PrP antibody response by oral inoculation of the PrP protein expressed in an attenuated Salmonella vector. This past study showed that 30% of vaccinated animals were free of disease more than 350 days post-challenge. In the current study we have both optimized the vaccination protocol and divided the vaccinated mice into low and high immune responder groups prior to oral challenge with PrP(Sc) scrapie strain 139A. These methodological refinements led to a significantly improved therapeutic response. 100% of mice with a high mucosal anti-PrP titer immunoglobulin (Ig) A and a high systemic IgG titer, prior to challenge, remained without symptoms of PrP infection at 400 days (log-rank test P<0.0001 versus sham controls). The brains from these surviving clinically asymptomatic mice were free of PrP(Sc) infection by Western blot and histological examination. These promising findings suggest that effective mucosal vaccination is a feasible and useful method for overcoming tolerance to PrP and preventing prion infection via an oral route.
Asunto(s)
Anticuerpos/sangre , Priones/inmunología , Scrapie/prevención & control , Vacunas/administración & dosificación , Administración Oral , Animales , Western Blotting , Encéfalo/patología , Ensayo de Inmunoadsorción Enzimática , Inmunoglobulina A/sangre , Inmunoglobulina A/inmunología , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Ratones , Scrapie/patología , Vacunación/métodos , Vacunas/inmunología , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/inmunologíaRESUMEN
The complete sequence of a gamma 2-H chain disease protein BUR is presented. This mutant, a dimer of a 348-residue chain, linked by four disulfide bridges, is composed of a complete V region, hinge, CH2, and CH3 domains. There is one deletion, the CH1 domain, which includes the cysteine residue bridging the H to L chain. Although the V region is encoded by the VHI and JHIII genes, it has several distinctions: methionine at position 11, two unique cysteine residues in the second complementarity determining region (CDR2), and three glycosylation sites, two of which are located in the CDR2 and CDR3 regions. These distinctive characteristics of BUR VH within the framework of a normal VHI may be affected by extensive somatic mutation or by a rare and previously unanalyzed VH gene.
Asunto(s)
Genes de Inmunoglobulinas , Enfermedad de las Cadenas Pesadas/genética , Inmunoglobulina G/genética , Secuencia de Aminoácidos , Deleción Cromosómica , Femenino , Humanos , Inmunoglobulina G/química , Datos de Secuencia Molecular , Peso Molecular , Fragmentos de Péptidos/químicaRESUMEN
The amino acid sequence of human tissue amyloid P component (AP) extracted by a modified method from the spleen of a patient with primary idiopathic amyloidosis was determined. AP is a glycoprotein composed of a pair of noncovalently bound pentameric discs with a subunit size of 23-25 kDa. Each subunit consists of 204 residues, a single disulfide bridge linking Cys 36 to Cys 95, and a carbohydrate moiety attached to Asn 32. The precursor of AP is the serum amyloid protein (SAP). The primary structure of AP presented here differs from the amino acid sequence of SAP previously reported, but is identical to the amino acid sequence of mature SAP deduced from the nucleotide sequence of complementary DNA clones. It shares 52% homology with the amended sequence of human C-reactive protein, an acute phase protein, and 68% homology with the Syrian hamster "female protein," another acute phase protein whose response is modulated by sex steroids. AP/SAP, C-reactive protein, and female protein belong to a family of plasma proteins called pentraxins and their considerable sequence homology is probably the result of gene duplication. Neither the physiological function of AP nor its possible pathological role in amyloidosis are yet known.
Asunto(s)
Amiloide , Amiloidosis/metabolismo , Bazo/análisis , Secuencia de Aminoácidos , Amiloide/aislamiento & purificación , Amiloide/metabolismo , Animales , Cromatografía en Gel , Cricetinae , Bromuro de Cianógeno , Humanos , Mesocricetus , Peso Molecular , Fragmentos de Péptidos/aislamiento & purificación , Fragmentos de Péptidos/metabolismo , Componente Amiloide P Sérico , Tripsina/metabolismoRESUMEN
The complete amino acid sequences of two related AA proteins (Mr 9700 and 5300) derived from thyroid tissue from a patient, NOR, with the autosomal recessive disease familial Mediterranean fever were determined. Heterogeneity found at position 52 indicates these proteins are fragments of two allelic or isotypic SAA precursor molecules similarly degraded at unusual sites and deposited in the thyroid. Degradation appears to be tissue and/or enzyme(s) specific since the carboxy terminus of both fragments is Ala-Ala and is different from other AA amyloid fibrils extracted from various tissues in different patients. Electron micrographic studies reveal these fragments retain the characteristics of native amyloid fibrils under physiological conditions even after exposure to dissociating agents.
Asunto(s)
Proteína Amiloide A Sérica/genética , Alelos , Secuencia de Aminoácidos , Amiloidosis/genética , Amiloidosis/metabolismo , Humanos , Datos de Secuencia Molecular , Fragmentos de Péptidos/análisis , Proteína Amiloide A Sérica/aislamiento & purificación , Proteína Amiloide A Sérica/metabolismo , Glándula Tiroides/metabolismo , TripsinaRESUMEN
Protein WIS is a human gamma3 heavy (H) chain disease immunoglobulin variant whose amino acid sequence is most readily interpreted by postulating that three residues of the amino terminus are followed by a deletion of most of the variable (VH) domain, which ends at the variable-constant (VC) joining region. Then there is a stretch of eight residues, three of which are unusual, while the other five have striking homology to the VC junction sequence. This is followed by a second deletion, which ends at the beginning of the quadruplicated hinge region. These findings are consistent with mutations resulting in deletions of most of the gene coding for the V region and CH1 domain followed by splicing at the VC joining region and at the hinge. These structural features fit well the notion of genetic discontinuity between V and C genes and also suggest similar mechanisms of excision and splicing in the interdomain regions of the C gene of the heavy chain.
Asunto(s)
Genes , Enfermedad de las Cadenas Pesadas/genética , Cadenas Pesadas de Inmunoglobulina/genética , Cadenas gamma de Inmunoglobulina/genética , Secuencia de Aminoácidos , Deleción Cromosómica , Humanos , Fragmentos de Inmunoglobulinas/genéticaRESUMEN
The complete sequence of a gamma 3 heavy-chain disease (HCD) protein Wis is presented. The molecule is a dimer of a 289-residue chain linked by 12 disulfide bonds. Protein Wis has an unusual amino terminus, followed by a deletion of most of the VH domain. After a small stretch homologous to the VC joining region, there is a second deletion which ends at the beginning of the quadruplicated hinge. Two carbohydrate groups are linked to Asn-6 and -140. the molecule has an extra interchain disulfide bridge at position 7 in addition to the 11 normally present in the quadruplicated hinge. The previously noted homology to the gamma 1 heavy chain is striking; from positions 224 to 234, protein Wis resembles gamma 1 Nei [Ponstingl, H., & Hilschmann, N. (1976) Hoppe-Seyler's Z. Physiol. Chem. 357, 1571--1604] except for a serine which replaces Asn at position 227. The results, taken together with studies of other immunoglobulin heavy-chain deletion mutants, support the suggestion that the different domains and interdomain regions of human H chains are coded for by different gene segments and that the deleted proteins reflect alterations in the recombination of different genes and/or the splicing of heterogeneous nuclear messenger ribonucleic acid (hn mRNA).
Asunto(s)
Deleción Cromosómica , Enfermedad de las Cadenas Pesadas/inmunología , Cadenas Pesadas de Inmunoglobulina , Cadenas gamma de Inmunoglobulina , Proteínas de Mieloma , Secuencia de Aminoácidos , Bromuro de Cianógeno , Enfermedad de las Cadenas Pesadas/genética , Humanos , Sustancias Macromoleculares , Peso Molecular , Mutación , Papaína , Pepsina A , Fragmentos de Péptidos/análisisRESUMEN
Human amyloid A protein (AA) is usually composed of the NH2-terminal 76 amino acid residue of serum amyloid A protein (SAA), although lower and higher molecular weight fragments have been reported. We studied the primary structure of six AA proteins with molecular weights of 11 kDA-15kDA, as determined by SDS-PAGE. Automated Edman degradation of the intact purified proteins and sequence analysis of enzymatic peptides revealed that the AA proteins were composed of only 74 to 87 residues. Moreover, fragments of apolipoprotein E or histones 2a, 3 and 4 were associated with these AA molecules. Thus, AA heterogeneity may reflect diverse processing of the SAA precursor and a very close association with other proteins.